Consequently, this study unraveled MYC, EGFR, and CCND1 to be the key genes and p53, cell cycle, PI3K-Akt, and MAPK pathways the key pathways for the regulatory effect of chemoresistance in ovarian cancer. This evidence concerns the gene MYC and ovarian cancer.